Heartburn Clinical Trial
Official title:
A Phase II, Randomized, Double-blind, Placebo-controlled, Parallel Group Proof-of-Concept Trial to Assess Relief of Meal Induced Heartburn by a Combination of Lansoprazole 15 mg and Antacid Versus Lansoprazole 15 mg and Antacid (Calcium Carbonate and Magnesium Hydroxide) Alone
This study will investigate the safety and efficacy of an antacid/Lansoprazole combination product for the relief of heartburn after consuming a heartburn-inducing meal.
n/a
Allocation: Randomized, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06094062 -
Smartphone App-assisted PPI
|
N/A | |
| Completed |
NCT00481949 -
Assessment of Gastro-esophageal Reflux Using Endo-Flip vs Bravo
|
N/A | |
| Completed |
NCT04560595 -
Remote Guided Caffeine Reduction
|
N/A | |
| Recruiting |
NCT01696734 -
Domperidone in Treating Patients With Gastrointestinal Disorders
|
Phase 3 | |
| Recruiting |
NCT02105090 -
Efficacy Study of Articaine Lozenge to Enhance the Procedural Compliance of the Adults Undergoing Gastroduodenoscopy
|
Phase 4 | |
| Completed |
NCT01338077 -
Efficacy and Safety of Sodium Alginate Oral Suspension to Treat Non-erosive Gastro-esophageal Reflux Disease
|
Phase 3 | |
| Completed |
NCT01005251 -
Investigate the Effect of Different Doses of Lesogaberan (AZD3355) as add-on to PPI in GERD Patients With Partial Response to PPI
|
Phase 2 | |
| Terminated |
NCT00536328 -
What is the Predictive Value of the Reflux Impact Scale
|
N/A | |
| Completed |
NCT00382577 -
Efficacy and Safety of Itopride vs Placebo in Heartburn
|
Phase 3 | |
| Completed |
NCT00236184 -
E3810-A001-313: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers
|
Phase 3 | |
| Completed |
NCT00236197 -
E3810-A001-312: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers
|
Phase 3 | |
| Completed |
NCT00236392 -
A Study of Efficacy and Safety of "On-demand" Maintenance Therapy With Rabeprazole in Patients With Non-erosive Reflux Disease (NERD)
|
Phase 3 | |
| Completed |
NCT04153552 -
Upset Stomach Relief for Mild and Moderate Indigestion and Heartburn
|
N/A | |
| Recruiting |
NCT06075082 -
The Effect of the LEFT Smartwatch App as Sleep Positional Therapy for Nocturnal Gastroesophageal Reflux Symptoms.
|
N/A | |
| Completed |
NCT05247333 -
Implementation of a Minor Ailment Service in Community Pharmacy Practice
|
N/A | |
| Recruiting |
NCT02277886 -
Esomeprazole Plus Alginate vs. Esomeprazole Alone for Treatment of Nighttime Reflux Symptom and Sleep Disturbances
|
Phase 4 | |
| Completed |
NCT01249651 -
To Assess the Efficacy of Esomeprazole 40 mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole
|
Phase 4 | |
| Completed |
NCT00588939 -
Confocal Laser Microscopy in Non Erosive Reflux Disease
|
N/A | |
| Completed |
NCT00206024 -
Acid-Associated Heartburn Symptoms and Dose of Esomeprazole
|
Phase 4 | |
| Recruiting |
NCT05976165 -
A Study of Breath Testing for Small Intestinal Bacterial Overgrowth
|
N/A |